MedTrace Logo

Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma

NCT04191447 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2022-07-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Flamboyant 200/12 association in adults with asthma.

Conditions

Interventions

DRUG

Flamboyant 200/12

Flamboyant 200/12 capsule

DRUG

Budesonide / Formoterol 400/12

Budesonide / Formoterol 400/12 capsule

OTHER

Flamboyant 200/12 Placebo

Flamboyant 200/12 Placebo capsule

OTHER

Budesonide / Formoterol 400/12 Placebo

Budesonide / Formoterol 400/12 Placebo capsule

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-22
Primary Completion
2023-07-31
Completion
2023-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04191447 on ClinicalTrials.gov